Biotechnology startup’s re-targeting approach offers novel take on drug development
A biotechnology startup has developed a technology platform that analyzes drugs to identify previously unrecognized targets and assess the best new use for them. The company’s approach is designed to cut the time and money spent on research and development with the potential to transform drug development. NPharmakon’s approach involves a platform that uses a proprietary […]